Clinical Trials

Sanjay Vyas, President and Managing Director, Parexel India, highlights that as India strengthens its position in global…

GlobalData’s latest report reveals that although opinions varied, the respondents agreed that AI has the capacity to both:…

Merck faces setback as Keytruda combination trials fail to expand cancer treatment ahead of patent loss

The number of single-country, interventional trials conducted by institutes has surged at a compound annual growth rate of 28 per…

China, India, and South Korea among the top three countries

Clinical trials have demonstrated PresVu's efficacy in enhancing close-up vision within minutes of application

Eyestem’s Eyecyte RPE therapy aims to replace lost or damaged retinal pigment epithelium (RPE) cells

Vivek Chopra, Partner, Vector Consulting Group, and Alka, Senior Consultant, Vector Consulting Group detail the evolving role of…

Under the agreement, JFCR will join Parexel’s Global Site Alliance network for oncology clinical trials and providing more…

ZYIL1 is a novel oral small molecule NLRP3 inhibitor. Studies have demonstrated that ZYIL1 is highly potent and can suppress…